Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
It is equally important to inform your healthcare provider of any other medications that you are taking before starting this medication
Augmenting research consent: should large language models (llms) be used for informed consent to clinical research
B12 has become something of an it supplement lately, with celebrities getting B12 shots after pulling all-nighters and athletes using them to enhance recovery
Walk-ins welcome no appointment necessary
The relationship between body weight and optimal dosing has not been established through controlled trials